Advertisement
| first line antiretroviral therapy: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection World Health Organization, 2016 These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly. |
| first line antiretroviral therapy: Disease Control Priorities, Third Edition (Volume 6) King K. Holmes, Stefano Bertozzi, Barry R. Bloom, Prabhat Jha, 2017-11-06 Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings. |
| first line antiretroviral therapy: Pocket Book of Hospital Care for Children World Health Organization, 2013 The Pocket Book is for use by doctors nurses and other health workers who are responsible for the care of young children at the first level referral hospitals. This second edition is based on evidence from several WHO updated and published clinical guidelines. It is for use in both inpatient and outpatient care in small hospitals with basic laboratory facilities and essential medicines. In some settings these guidelines can be used in any facilities where sick children are admitted for inpatient care. The Pocket Book is one of a series of documents and tools that support the Integrated Managem. |
| first line antiretroviral therapy: Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence World Health Organization. Department of Mental Health and Substance Abuse, World Health Organization, 2009 These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the United Nations Office on Drugs and Crime (UNODC) a Guidelines Development Group of technical experts, and in consultation with the International Narcotics Control Board (INCB) secretariat and other WHO departments. WHO also wishes to acknowledge the financial contribution of UNODC and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to this project. - p. iv |
| first line antiretroviral therapy: Handbook of Antimicrobial Resistance Matthias Gotte, Albert Berghuis, Greg Matlashewski, Mark Wainberg, Donald Sheppard, 2018-02-12 While many volumes have been written about various aspects of antimicrobial resistance, this book is a comprehensive reference work. All manifestations of resistance are addressed: viral; bacterial, parasitical and fungal are given dedicated sections. The underlining molecular mechanisms, which depend not only on the microbe but on the specific drug (target), are highly diverse. This work discusses and compares the biological, biochemical and structural aspects of resistance and its evolution. |
| first line antiretroviral therapy: Encyclopedia of AIDS Thomas J. Hope, Mario Stevenson, Douglas Richman, |
| first line antiretroviral therapy: Nutrition and HIV/AIDS Nancy Dumais, 2020-04-29 This edited volume, “Nutrition and HIV/AIDS - Implication for Treatment, Prevention and Cure”, is a collection of reviewed and relevant research chapters, offering a comprehensive overview of recent developments in the field. The book comprises single chapters authored by various researchers and edited by an expert active in the research area. All chapters are complete in themselves but united under a common research study topic. This publication aims at providing a thorough overview of the latest research efforts by international authors and opening new possible research paths for further novel developments. |
| first line antiretroviral therapy: Ethics and Drug Resistance: Collective Responsibility for Global Public Health Euzebiusz Jamrozik, Michael Selgelid, 2021-08-21 This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century. |
| first line antiretroviral therapy: Global Report on Diabetes Gojka Roglic, 2016 On the occasion of World Health Day 2016, WHO issues a call for action on diabetes, drawing attention to the need to step up prevention and treatment of the disease. The first WHO Global report on diabetes demonstrates that the number of adults living with diabetes has almost quadrupled since 1980 to 422 million adults. This dramatic rise is largely due to the rise in type 2 diabetes and factors driving it include overweight and obesity. In 2012 alone diabetes caused 1.5 million deaths. Its complications can lead to heart attack, stroke, blindness, kidney failure and lower limb amputation. The new report calls upon governments to ensure that people are able to make healthy choices and that health systems are able to diagnose, treat and care for people with diabetes. It encourages us all as individuals to eat healthily, be physically active, and avoid excessive weight gain.--Publisher's description. |
| first line antiretroviral therapy: CDC Yellow Book 2018: Health Information for International Travel Centers for Disease Control and Prevention CDC, 2017-04-17 THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad. |
| first line antiretroviral therapy: Acute Care Handbook for Physical Therapists - E-Book Jaime C. Paz, Michele P. West, 2013-10-04 - NEW! Restructured table of contents helps you quickly locate information. - NEW! Language from the International Classification of Functioning, Disability, and Health (ICF) model adopted by the American Physical Therapy Association increases your familiarity with terminology. - NEW! New intervention algorithms along with existing algorithms break clinical decision-making into individual steps and sharpens your on-the-spot critical-thinking skills. - NEW! A quick-reference appendix covering abbreviations commonly found in the acute care environment supplies the translation tools you need, while flagging any abbreviations that may be harmful to the patient. |
| first line antiretroviral therapy: HIV Vaccines and Cure Linqi Zhang, Sharon R. Lewin, 2018-07-20 This book provides a comprehensive review of the major barriers to HIV cure and vaccine. It covers the fundamental virology and immunology leading to HIV transmission, protection from infection and long term HIV persistence on antiretroviral therapy. In addition, strategies being tested to eliminate persistent HIV and the rational design of vaccines to induce protective immunity are covered. This book also discusses the challenges related to the design of clinical trials for testing the safety and efficacy of these innovative approaches. This book will provide a systematic overview and also discuss controversial issues for researchers in virology and immunology, as well as practicing physicians, and scientists in the pharmaceutical industry. |
| first line antiretroviral therapy: HIV/AIDS Treatment and Care Irina Eramova, Srdan Matic, Monique Munz, 2007 The WHO Regional Office for Europe has combined its 13 protocols on treatment of and care for people with HIV and AIDS in one volume. The protocols are the cornerstone of the strategic actions that WHO has taken as part of its contribution to achieving the goal of universal access to HIV/AIDS prevention, treatment, care and support services. The protocols were specifically developed for the entire WHO European Region. Together, they represent a comprehensive and evidence-based tool that offers health professionals clear and specific advice on diagnosing and managing a wide range of health issues related to HIV/AIDS for adults, adolescents and children, including antiretroviral treatment, the management of opportunistic infections, tuberculosis, hepatitis, injecting drug use, sexual and reproductive health, the prevention of mother-to-child HIV transmission, immunization, palliative care and post-exposure prophylaxis. [Ed.] |
| first line antiretroviral therapy: The Neurology of HIV Infection , 2018-03-29 The Neurology of HIV Infection covers all aspects of nervous system involvement and pathology in HIV-infected individuals. Specialists in this field cover epidemiology, global aspects, pathology and pathogenesis of nervous system disease in HIV-infection. All complications, including the pathology caused by HIV itself and all opportunistic infections of the nervous system are reviewed in detail. Both central nervous and peripheral nervous system complications, including neuropathies and myopathies, are discussed. Key chapters on global developments, HIV-associated neurocognitive disorders, IRIS, stroke and neuro-aids in children complete this volume. - Covers all aspects of nervous system involvement and pathology in HIV-infected individuals - Includes the pathology caused by HIV and all opportunistic infections of the nervous system - Presents key chapters that focus on global developments, HIV-associated neurocognitive disorders, IRIS, stroke and neuro-aids in children |
| first line antiretroviral therapy: Practice Guideline for the Treatment of Patients with HIV/AIDS American Psychiatric Association, 2000 This practice guideline seeks to summarize data and specific forms of treatment regarding the care of patients with HIV/AIDS. The purpose of this guideline is to assist the psychiatrist in caring for a patient with HIV/AIDS by reviewing the treatments that patients with HIV/AIDS may need. |
| first line antiretroviral therapy: WHO consolidated guidelines on drug-resistant tuberculosis treatment World Health Organization, 2018-11-07 Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care. |
| first line antiretroviral therapy: Virus Dynamics : Mathematical Principles of Immunology and Virology Martin Nowak, Robert M. May, 2000-11-23 This groundbreaking book describes the emerging field of theoretical immunology, in particular the use of mathematical models to describe the spread of infectious diseases within patients. It reveals fascinating insights into the dynamics of viral and other infections, and the interactions between infectious agents and immune responses. Structured around the examples of HIV/AIDS and hepatitis B, Nowak and May show how mathematical models can help researchers to understand the detailed dynamics of infection and the effects of antiviral therapy. Models are developed to describe the dynamics of drug resistance, immune responses, viral evolution and mutation, and to optimise the design of therapy and vaccines. - ;We know, down to the tiniest details, the molecular structure of the human immunodeficiency virus (HIV). Yet despite this tremendous accomplishment, and despite other remarkable advances in our understanding of individual viruses and cells of the immune system, we still have no agreed understanding of the ultimate course and variability of the pathogenesis of AIDS. Gaps in our understanding like these impede our efforts towards developing effective therapies and preventive vaccines. Martin Nowak and Robert M May describe the emerging field of theoretical immunology in this accessible and well- written text. Using mathematical modelling techniques, the authors set out their ideas about how populations of viruses and populations of immune system cells may interact in various circumstances, and how infectious diseases spread within patients. They explain how this approach to understanding infectious diseases can reveal insights into the dynamics of viral and other infections, and the interactions between infectious agents and immune responses. The book is structured around the examples of HIV/AIDS and Hepatitis B virus, although the approaches described will be more widely applicable. The authors use mathematical tools to uncover the detailed dynamics of the infection and the effects of antiviral therapy. Models are developed to describe the emergence of drug resistance, and the dynamics of immune responses, viral evolution, and mutation. The practical implications of this work for optimisation of the design of therapy and vaccines are discussed. The book concludes with a glance towards the future of this fascinating, and potentially highly useful, field of study. - ;... an excellent introduction to a field that has the potential to advance substantially our understanding of the complex interplay between virus and host - Nature |
| first line antiretroviral therapy: Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care World Health Organization, 2017-06 The update of the Guidelines for Treatment of Drug-susceptible Tuberculosis and Patient Care is important in the context of the End TB Strategy, which recommends treatment and patient support for all people with TB. This update aims to use the best available evidence on the treatment of drug-susceptible TB and interventions to ensure adequate patient care and support in order to inform policy decisions made in these technical areas by national TB control program managers, national policy-makers, and medical practitioners in a variety of geographical, economic, and social settings. The objectives of these updated guidelines are to provide updated recommendations based on newly emerged evidence on the treatment of drug-susceptible TB and patient care as well as provide a summary of changes in the new guidelines with all the existing and valid WHO recommendations on the treatment of drug-susceptible TB and TB patient care. The key audience for these guidelines are policy-makers in ministries of health or managers of national TB programs who formulate country-specific TB treatment guidelines or who plan TB treatment programs. In addition, health professionals - including doctors, nurses, and educators working both in government services and nongovernmental organizations, such as technical agencies that are treating patients and organizing treatment services - will find these guidelines to be useful. |
| first line antiretroviral therapy: Antibiotic and Chemotherapy Roger G. Finch, 2003 The completely revised and updated New Edition of this respected resource presents globally-relevant coverage of all types of antimicrobial agents used in human medicine, providing authoritative guidance on the principles and practice of antimicrobial chemotherapy. In addition to full coverage of every commonly used antibiotic agent, it includes complete coverage of all antiviral, antiprotozoan and anthelminthic agents. And, its unique 3-part structure makes it easy to locate information: Part I covers general aspects of treatment; Part II reviews every agent, including antimicrobial activity, pharmacokinetics, clinical use, and available preparations; Part III details the treatment of particular infections. Discusses the increasing problem of multi-drug resistance and the wide range of new antiviral therapies now available for the treatment of HIV and other viral infections. Reviews all of the new antimicrobial agents in detail. Features more clinically focused sections on Pharmacokinetics. Details new antifungal therapies, including voriconazole, liposomal, and amphotericin B. Presents new tables on major drug interactions, placental transfer, and concentrations of agents in breast milk. Features new sections on liver failure, drug development and licensing, and the implications of xenotransplantation. Presents expanded coverage of Quinolone as well as new antimalarial combination therapies. Offers cross-references to key web sites, for up-to-date information on treatment and drug resistance. |
| first line antiretroviral therapy: Global AIDS Monitoring 2019 United Nations Publications, 2019-04-17 The purpose of this document is to provide guidance to national AIDS programmes and partners on the use of indicators to measure and report on the country response. The 2016 United Nations Political Declaration on Ending AIDS, adopted at the United Nations General Assembly High-Level Meeting on AIDS in June 2016, mandated UNAIDS to support countries in reporting on the commitments in the Political Declaration. The Political Declaration on Ending AIDS built on three previous political declarations: the 2001 Declaration of Commitment on HIV/AIDS, the 2006 Political Declaration on HIV/AIDS and the 2011 Political Declaration on HIV and AIDS. |
| first line antiretroviral therapy: Journsl Independently Published, 2020-07-11 6x9/BlackLined/White/120pages A Journal for you to write down your heart's contents, to take notes, practice your creative writing, write down your to-do-lists or simply enjoy journaling. |
| first line antiretroviral therapy: Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring World Health Organization, 2021-07-16 These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016. It serves as an update to the previous edition of the consolidated guidelines on HIV. These guidelines continue to be structured along the continuum of HIV care. Information on new combination prevention approaches, HIV testing, ARV regimens and treatment monitoring are included. There is a new chapter on advanced HIV disease that integrates updated guidance on the management of important HIV comorbidities, including cryptococcal disease, histoplasmosis and tuberculosis. The chapter on general HIV care, contains a new section on palliative care and pain management, and up to date information on treatment of several neglected tropical diseases, such as visceral leishmaniasis and Buruli ulcer. New recommendations for screening and treating of cervical pre-cancer lesions in women living with HIV are also addressed in this chapter. Guidance on service delivery was expanded to help the implementation and strengthening the HIV care cascade. Importantly, this guidance emphasizes the need for differentiated approaches to care for people who are established on ART, such as reduced frequency of clinic visits, use of multi-month drug dispensing and implementation of community ART distribution. The adoption of these efficiencies is essential to improve the quality of care of people receiving treatment and reduce the burden on health facilities, particularly in resource limited settings. |
| first line antiretroviral therapy: The Pocket Guide for HIV and AIDS Nursing Care Ansie Minnaar, Candice Bodkin, 2006 Offering practical solutions to the problems associated with nursing care for HIV and AIDS patients, this resource is written by two highly experienced nurses from the context of both the healthcare and home environments. Designed as an easily accessible, quick-reference guide, topics include HIV and pregnancy, pediatric management, dealing with infections, and the principles of anti-retroviral therapy. Additional chapters include counseling and living positively with HIV and AIDS. The most recent research is presented and the interactive approach makes the task of putting theory into practice achievable. |
| first line antiretroviral therapy: , |
| first line antiretroviral therapy: Advances in Pediatrics Anupam Sachdeva, AK Dutta, 2012-08-31 |
| first line antiretroviral therapy: Antiretroviral medicines in low- and middle-income countries , 2022-02-16 |
| first line antiretroviral therapy: Little Black Book of International Medicine William Alto, 2009-09-22 Each year, thousands of US physicians, nurses, and other healthcare workers volunteer or are called on to practice medicine in a foreign country. The Little Black Book of International Medicine provides comprehensive, concise and evidence-based information to setting up a medical clinic and treating patients outside the US, especially in developing countries. This pocket-sized handbook is a convenient resource offering immediate access to vital information and makes a great reference for solving pressing problems in the field. |
| first line antiretroviral therapy: Considerations for introducing new antiretroviral drug formulations for children World Health Organization, 2020-07-01 |
| first line antiretroviral therapy: Fundamentals of HIV Medicine 2021 W. David Hardy, 2021-06-08 The essential work in HIV for providers and pharmacists--updated with everything they need to know in 2021! An end-to-end clinical resource for the treatment of individuals with HIV/AIDS, Fundamentals of HIV Medicine has served as a key resource for clinicians preventing and treating HIV for over a decade. Now updated for 2021, Fundamentals of HIV Medicine 2021 offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, nurses, and other professionals working in the care of HIV patients. With this volume, practitioners will have immediate, indexed access to the most updated science, research, and guidelines related to all aspects of HIV care and prevention. This revised edition features key clinical updates across classic domains of HIV medicine along with recent research in HIV medicine including HIV workforce strains and PrEP, newly emerging antiretroviral treatment options, and the evolving effects of COVID-19 on HIV care. Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2021 is a must-have for health professionals across HIV care, treatment, and prevention. |
| first line antiretroviral therapy: District Laboratory Practice in Tropical Countries, Part 2 Monica Cheesbrough, 2006-03-02 This new edition includes an update on HIV disease/AIDS, recently developed HIV rapid tests to diagnose HIV infection and screen donor blood, and current information on antiretroviral drugs and the laboratory monitoring of antiretroviral therapy. Information on the epidemiology and laboratory investigation of other pathogens has also been brought up to date. Several new, rapid, simple to perform immunochromatographic tests to assist in the diagnosis of infectious diseases are described, including those for brucellosis, cholera, dengue, leptospirosis, syphilis and hepatitis. Recently developed lgM antibody tests to investigate typhoid fever are also described. The new classification of salmonellae has been introduced. Details of manufacturers and suppliers now include website information and e-mail addresses. The haematology and blood transfusion chapters have been updated, including a review of haemoglobin measurement methods in consideration of the high prevalence of anaemia in developing countries. |
| first line antiretroviral therapy: Targeted Learning Mark J. van der Laan, Sherri Rose, 2011-06-17 The statistics profession is at a unique point in history. The need for valid statistical tools is greater than ever; data sets are massive, often measuring hundreds of thousands of measurements for a single subject. The field is ready to move towards clear objective benchmarks under which tools can be evaluated. Targeted learning allows (1) the full generalization and utilization of cross-validation as an estimator selection tool so that the subjective choices made by humans are now made by the machine, and (2) targeting the fitting of the probability distribution of the data toward the target parameter representing the scientific question of interest. This book is aimed at both statisticians and applied researchers interested in causal inference and general effect estimation for observational and experimental data. Part I is an accessible introduction to super learning and the targeted maximum likelihood estimator, including related concepts necessary to understand and apply these methods. Parts II-IX handle complex data structures and topics applied researchers will immediately recognize from their own research, including time-to-event outcomes, direct and indirect effects, positivity violations, case-control studies, censored data, longitudinal data, and genomic studies. |
| first line antiretroviral therapy: ABC of HIV and AIDS Michael W. Adler, Simon G. Edwards, Robert F. Miller, Gulshan Sethi, Ian Williams, 2012-07-23 An authoritative guide to the epidemiology, incidence, testing and diagnosis and management of HIV and AIDS. From an international expert editor and contributor team, this new sixth edition includes expanded coverage of HIV testing, assessment and routine follow up and new chapters outlining problematic conditions associated with HIV and AIDS. Prevention strategies, early diagnosis and antiretroviral drugs and pharmacotherapy are covered in detail as well as children and women with HIV. It also addresses key psychological and mental health issues, patient perspectives and the role of patient engagement. As knowledge into the illness grows and major advances in HIV therapy see more people living with HIV in the community, the ABC of HIV and AIDS, 6e provides clear practical guidance for general practitioners, hospital doctors, nurses, medical students, counsellors, allied health workers and anyone working and caring for patients with HIV and AIDS. |
| first line antiretroviral therapy: Medicine Update 2019 & Progress in Medicine 2019 KK Pareek, G Narsimulu, 2019-05-31 (Medicine Update 2019_2 Volumes) SECTION 1: CARDIOLOGY SECTION 2: HYPERTENSION SECTION 3: PULMONOLOGY SECTION 4: ENDOCRINOLOGY SECTION 5: DIABETOLOGY SECTION 6: NEUROLOGY SECTION 7: RHEUMATOLOGY SECTION 8: NEPHROLOGY SECTION 9: GASTROENTEROLOGY AND HEPATOLOGY SECTION 10: ONCOLOGY AND HEMATOLOGY SECTION 11: INFECTIOUS DISEASES SECTION 12: CRITICAL CARE MEDICINE SECTION 13: POISIONING AND TOXICOLOGY SECTION 14: PREGNANCY SECTION 15: HIV SECTION 16: GERIATRICS SECTION 17: LIPIDOLOGY SECTION 18: NUTRITION SECTION 19: ENVIRONMENTAL MEDICINE SECTION 20: MISCELLANEOUS (Progress in Medicine 2019) SECTION 1: CARDIOLOGY SECTION 2: ENDOCRINOLOGY AND DIABETOLOGY SECTION 3: GASTROENTEROLOGY SECTION 4: GERIATRICS SECTION 5: GENERAL MEDICINE SECTION 6: INFECTIOUS DISEASES SECTION 7: NEPHROLOGY SECTION 8: NEUROLOGY SECTION 9: ONCOLOGY SECTION 10: PULMONOLOGY SECTION 11: POISONING SECTION 12: RABINDRANATH TAGORE ORATION SECTION 13: RHEUMATOLOGY Index |
| first line antiretroviral therapy: WHO HIVResNet meeting report, Johannesburg, South Africa, 19 October 2019 , 2021-02-15 |
| first line antiretroviral therapy: Microbes, Viruses and Parasites in AIDS Process Vladimír Zajac, 2011-10-21 The main goal in compiling this book was to highlight the situation in Africa in terms of AIDS and opportunistic diseases. Several chapters reveal great poverty, an apocalyptic situation in many parts of Africa. Global migration of people resulted in their exposure to pathogens from all over the world. This fact has to be acknowledged and accepted as African reality. New, unconventional hypotheses, not determined by established dogmas, have been incorporated into the book, although they have not yet been sufficiently validated experimentally. It still applies that any dogma in any area of science, and medicine in particular, has and always will hinder progress. According to some biologists, in the future, AIDS is very likely to occur in a number of variations, as a direct result of the ongoing processes in the global human society. Thus, we urgently need a comprehensive solution for AIDS, in order to be ready to fight other, much more dangerous intruders. |
| first line antiretroviral therapy: Issues in Discovery, Experimental, and Laboratory Medicine: 2011 Edition , 2012-01-09 Issues in Discovery, Experimental, and Laboratory Medicine: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Discovery, Experimental, and Laboratory Medicine. The editors have built Issues in Discovery, Experimental, and Laboratory Medicine: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Discovery, Experimental, and Laboratory Medicine in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Discovery, Experimental, and Laboratory Medicine: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| first line antiretroviral therapy: Rural Health - Investment, Research and Implications Christian Rusangwa, 2023-11-15 In this eye-opening exploration, the authors bring together years of research, on-the-ground insights, and a vision for the future of rural health. Through engaging narratives, data-driven analysis, and thought-provoking case studies, this book sheds light on the critical issues that affect the well-being of millions living outside urban centers. Rural Health - Investment, Research and Implications is an essential read for healthcare professionals, policymakers, researchers, and anyone passionate about the well-being of rural communities. It offers a roadmap to a brighter, healthier future for those often left in the shadows, highlighting the immense potential of rural America and the transformative power of investment and research in shaping a more equitable healthcare landscape. Join the conversation, be part of the solution, and uncover the untapped potential of rural health. This book is a call to action for a healthier, more inclusive future for all. |
| first line antiretroviral therapy: China Engages Global Health Governance L. Chan, 2011-01-03 This book explores public health in China in particular the management of the HIV/AIDS epidemic, with the goal of understanding China's compliance with and resistance to the norms and rules embedded in the global health regime. |
| first line antiretroviral therapy: WHO operational handbook on tuberculosis. Module 5 World Health Organization, 2022-03-21 The aim of this operational handbook is to provide practical guidance on the implementation of the World Health Organization (WHO) policy recommendations on the prevention and management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The practical guidance aims to inform the development or revision of national policies and related implementation guidance (e.g. handbooks, standard operating procedures) on the management of TB in children and adolescents. This handbook can also help countries adequately plan for the uptake of interventions to better address the specific needs of children and adolescents with or at risk of TB. It can contribute to national efforts to build capacity among national and subnational programme managers and among health workers at all levels of the health care system. The target audience for this handbook includes NTPs and other child health programmes that provide care for children with or at risk of TB, including maternal, newborn, child and adolescent health programmes, HIV services, and PHC programmes. The handbook also targets paediatricians and other health care workers (HCWs) in the public and private sectors, school health services, civil society and community-based organizations, and health care educators. |
| first line antiretroviral therapy: Logan Turner's Diseases of the Nose, Throat and Ear, 10Ed Arthur Turner, 1987-12-30 'I am unaware of any textbook which provides such comprehensive coverage of the field and doubt that this work will be surpassed in the foreseeable future, if ever!' From the foreword by Robert C. Moellering, Jr., M.D, Shields Warren-Mallinckrodt Professor of Medical Research, Harvard Medical School, USA Kucers' The Use of Antibiotics is the leading major reference work in this vast and rapidly developing field. More than doubled in length compared to the fifth edition, the sixth edition comprises 3000 pages over 2-volumes in order to cover all new and existing therapies, and emerging drugs not yet fully licensed. Concentrating on the treatment of infectious diseases, the content is divided into 4 sections: antibiotics, anti-fungal drugs, anti-parasitic drugs and anti-viral drugs, and is highly structured for ease of reference.Within each section, each chapter is structured to cover susceptibility, formulations and dosing (adult and paediatric), pharmacokinetics and pharmacodynamics, toxicity and drug distribution, detailed discussion regarding clinical uses, a feature unique to this title. Compiled by an expanded team of internationally renowned and respected editors, with a vast number of contributors spanning Europe, Africa, Asia, Australia, South America, the US and Canada, the sixth edition adopts a truly global approach. It will remain invaluable for anyone using antimicrobial agents in their clinical practice and provides in a systematic and concise manner all the information required when treating infections requiring antimicrobial therapy. Kucers' The Use of Antibiotics is available free to purchasers of the books as an electronic version on line or on your desktop: It provides access to the entire 2-volume print material It is fully searchable, so you can find the relevant information you need quickly Live references are linked to PubMed referring you to the latest journal material Customise the contents - you can highlight sections and make notes Comments can be shared with colleagues/tutors for discussion, teaching and learning The text can also be reflowed for ease of reading Text and illustrations copied will be automatically referenced to Kucers' The Use of Antibiotics |
Last name 和 First name 到底哪个是名哪个是姓？ - 知乎
Last name 和 First name 到底哪个是名哪个是姓？ 上学的时候老师说因为英语文化中名在前，姓在后，所以Last name是姓，first name是名，假设一个中国人叫孙悟空，那么他的first nam…
first 和 firstly 的用法区别是什么？ - 知乎
a.First （ = First of all）I must finish this work.（含义即，先完成这项工作再说，因为这是必须的，重要的，至于其它，再说吧） b.First come，first served .先来，先招待（最重要） …
EndNote如何设置参考文献英文作者姓全称，名缩写？ - 知乎
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业、友善的社区 …
对一个陌生的英文名字，如何快速确定哪个是姓哪个是名？ - 知乎
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业、友善的社区 …
发表sci共同第一作者(排名第二)有用吗？ - 知乎
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业、友善的社区 …
Last name 和 First name 到底哪个是名哪个是姓？ - 知乎
Last name 和 First name 到底哪个是名哪个是姓？ 上学的时候老师说因为英语文化中名在前，姓在后，所以Last name是姓，first name是名，假设一个中国人叫孙悟空，那么他的first nam…
first 和 firstly 的用法区别是什么？ - 知乎
a.First （ = First of all）I must finish this work.（含义即，先完成这项工作再说，因为这是必须的，重要的，至于其它，再说吧） b.First come，first served .先来，先招待（最重要） …
EndNote如何设置参考文献英文作者姓全称，名缩写？ - 知乎
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业 …
对一个陌生的英文名字，如何快速确定哪个是姓哪个是名？ - 知乎
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业 …
发表sci共同第一作者(排名第二)有用吗？ - 知乎
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业 …
有大神公布一下Nature Communications从投出去到Online的审稿 …
知乎，中文互联网高质量的问答社区和创作者聚集的原创内容平台，于 2011 年 1 月正式上线，以「让人们更好的分享知识、经验和见解，找到自己的解答」为品牌使命。知乎凭借认真、专业 …
GM、VP、FVP、CIO都是什么职位？ - 知乎
FVP（First Vice President）则是指公司的第一副总裁，通常是在VP之上的高管职位。 VP（Vice President）是指公司的副总裁，通常是在高层管理团队中担任领导职务的高管。
论文作者后标注了共同一作（数字1）但没有解释标注还算共一 …
Aug 26, 2022 · 是在不同作者姓名的右上角标了数字1吗？ 共同作者可不是这么标的。 标注共同一作的方法并不是有的作者以为的上下并列，而是在共同第一作者的右上角标注相同的符号，比 …
贝塞尔函数及其性质 - 知乎
为第一类贝塞尔函数 (Bessel functions of the first kind)， 为第二类贝塞尔函数 (Bessel functions of the second kind)，有的也记为 。 第一类贝塞尔函数积分表达式. 对于整数阶n， 该公式也 …
2025年618 CPU选购指南丨CPU性能天梯图（R23 单核/多核性能跑 …
May 4, 2025 · cpu型号名称小知识 amd. 无后缀 ：普通型号; 后缀 g ：有高性能核显型号（5000系及之前系列 除了后缀有g的其他均为 无核显，7000除了后缀f，都有核显）
